A federal agency's approach to drug enforcement is under scrutiny. Republicans on a House committee are investigating a tactic that allowed large quantities of a dangerous drug to circulate. The committee chairman has requested records from the Attorney General related to this strategy.

Concerns about the approach were raised by officials and whistleblowers in a state heavily affected by the drug crisis. They reported being told not to intercept large shipments of the drug.

Further information about the investigation and the controversy surrounding the drug enforcement tactic is available from the source.